PSAP and nevoid basal cell carcinoma syndrome: For the disease cell models of Gorlin syndrome (VCV000654759) and the sphingolipid activator protein 1 deficiency (VCV000942712), ABE8e30 showed high correction efficiencies of 98% and 91% respectively.